Avedro Acquires IROC Innocross, Expands Cross-Linking Platform
With the addition of IROC Innocross' line of devices, Avedro's corneal cross-linking technology platform now spans the entire spectrum of procedures.
PiXL™: Untapped Opportunities in Refractive Correction
Join us for an ESCRS evening event featuring cross-linking thought-leaders speaking on advanced topics in corneal cross-linking.
The World Leader in Corneal Cross-Linking Science
Avedro's experienced team of scientists, engineers and software programmers have created the first and only FDA approved cross-linking system.
Avedro’s cross-linking systems and family of riboflavin products are not for sale in the US. MA-00285A